Benjamin J. Zeskind - 31 Dec 2021 Form 5 Insider Report for Immuneering Corp (IMRX)

Role
PRESIDENT AND CEO, Director, 10%+ Owner
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Benjamin J. Zeskind
Issuer symbol
IMRX
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
10 Feb 2022, 15:29:49 UTC
Previous filing
14 Sep 2021
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Gift $0 -350,000 -13% $0.000000 2,252,352 22 Oct 2021 Direct
transaction IMRX Class A Common Stock Gift $0 +350,000 +64% $0.000000 894,927 22 Oct 2021 See Foonote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.